Phase 2 Cytomegalovirus Clinical Trials
10 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–10 of 10 trials
Recruiting
Phase 2
Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)
Cytomegalovirus Viraemia
Murdoch Childrens Research Institute232 enrolled7 locationsNCT06574789
Recruiting
Phase 2
Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation
AdenovirusCytomegalovirus
St. Jude Children's Research Hospital42 enrolled1 locationNCT05664126
Recruiting
Phase 2
Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific Antibodies
Cytomegalovirus (CMV)
Seoul National University Hospital20 enrolled1 locationNCT07014319
Recruiting
Phase 1Phase 2
Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
Epstein-Barr Virus InfectionsCytomegalovirus InfectionsAdenovirus
Jessie L. Alexander25 enrolled3 locationsNCT06909110
Recruiting
Phase 2
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
Cytomegalovirus InfectionsPrimary Immune Deficiency Disorder
New York Medical College20 enrolled9 locationsNCT03266640
Recruiting
Phase 2
Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients
Cytomegalovirus InfectionsTransplant-Related Disorder
University of Pennsylvania80 enrolled1 locationNCT06066957
Recruiting
Phase 2
A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®
Cytomegalovirus InfectionsAdenovirus InfectionEBV+2 more
University Hospital, Basel, Switzerland30 enrolled1 locationNCT02007356
Recruiting
Phase 2
ATG Individualized Dosing Model in URD-PBSCT.
Stem Cell Transplant ComplicationsCytomegalovirus InfectionsInfection Reactivation
Chinese PLA General Hospital30 enrolled1 locationNCT06572462
Recruiting
Phase 2
A randomised trial of third-party virus-specific T cells in patients with untreated viral infection after an allogeneic stem cell transplantation
Cytomegalovirus (CMV) infection
Western Sydney Local Health District144 enrolled6 locationsACTRN12620000171910
Terminated
Phase 2
Adoptive immunotherapy for the prevention of Human Cytomegalovirus (HCMV) reactivation and disease after Allogenic Stem Cell Transplantation
Human Cytomegalovirus (HCMV) reactivation and disease after Allogenic Stem Cell Transplantation
Queensland Institute of Medical Research (QIMR)15 enrolled1 locationACTRN12605000452695